Possible role of excitotoxicity in the pathogenesis of glaucoma
- 1 January 2006
- journal article
- review article
- Published by Wiley in Clinical & Experimental Ophthalmology
- Vol. 34 (1) , 54-63
- https://doi.org/10.1111/j.1442-9071.2006.01146.x
Abstract
Excitotoxicity describes the process of neuronal injury by excess stimulation of amino acid receptors. This form of insult was first described in the retina, and subsequently has been shown to be an important component of the pathogenesis of ischaemic and traumatic injury in the central nervous system. Furthermore, there is increasing evidence that excitotoxicity is involved in several chronic neurological conditions, and anti‐excitotoxic treatment has already been approved for some of these conditions. A large‐scale trial is currently underway that will determine the efficacy of an anti‐excitotoxic drug (memantine) in the management of glaucoma. This review provides an overview of neurotransmission and the mechanisms of excitotoxicity. The evidence for excitotoxicity as a component of certain neurological diseases, including glaucoma, is discussed.Keywords
This publication has 103 references indexed in Scilit:
- Retinal vessel diameter and open-angle glaucomaOphthalmology, 2005
- Efficacy and Safety of Memantine Treatment for Reduction of Changes Associated with Experimental Glaucoma in Monkey, II: Structural MeasuresInvestigative Opthalmology & Visual Science, 2004
- Effects of Methylprednisolone on Extracellular Lactic Acidosis and Amino Acids After Severe Compression Injury of Rat Spinal CordJournal of Neurochemistry, 2002
- The distribution and developmental regulation of NMDA receptor subunit proteins in the outer and inner retina of the ratJournal of Neurobiology, 2000
- Neuronal death in glaucomaProgress in Retinal and Eye Research, 1998
- New inhibitors of calpain prevent degradation of cytoskeletal and myelin proteins in spinal cord in vitroJournal of Neuroscience Research, 1998
- Ameliorative Effect of MK-801 on Retinal IschemiaJournal of Ocular Pharmacology and Therapeutics, 1997
- Expression of NR1 and NR2A/B subunits of the NMDA receptor in cortical astrocytesGlia, 1996
- A Controlled Trial of Riluzole in Amyotrophic Lateral SclerosisNew England Journal of Medicine, 1994
- Changing subunit composition of heteromeric NMDA receptors during development of rat cortexNature, 1994